SRS Capital Advisors, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
SRS Capital Advisors, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$49,614
-16.6%
1,315
+0.7%
0.01%
-25.0%
Q2 2023$59,508
+13.1%
1,306
+0.7%
0.01%
+14.3%
Q1 2023$52,601
+6.8%
1,297
+34.3%
0.01%0.0%
Q4 2022$49,259
-3.4%
966
+2.9%
0.01%
-12.5%
Q3 2022$51,000
-15.0%
9390.0%0.01%
-11.1%
Q2 2022$60,000
-17.8%
939
+0.1%
0.01%
-10.0%
Q1 2022$73,000
-8.8%
938
+0.2%
0.01%0.0%
Q4 2021$80,000
+6.7%
936
+0.3%
0.01%0.0%
Q3 2021$75,000
+15.4%
933
+15.8%
0.01%
+11.1%
Q2 2021$65,000
+1.6%
806
+0.4%
0.01%0.0%
Q4 2020$64,0000.0%803
+0.2%
0.01%
-18.2%
Q3 2020$64,000
-58.7%
801
-55.5%
0.01%
-60.7%
Q2 2020$155,000
-41.3%
1,800
-44.7%
0.03%
-54.1%
Q1 2020$264,000
+5.2%
3,256
+8.3%
0.06%
-15.3%
Q4 2019$251,000
-4.6%
3,0060.0%0.07%
-8.9%
Q3 2019$263,000
+6.9%
3,0060.0%0.08%
-3.7%
Q2 2019$246,000
+24.2%
3,0060.0%0.08%
+3.8%
Q4 2018$198,000
+125.0%
3,006
+163.5%
0.08%
+125.7%
Q3 2018$88,000
-24.1%
1,141
-27.9%
0.04%
-31.4%
Q2 2018$116,000
+20.8%
1,583
+6.9%
0.05%
+2.0%
Q1 2018$96,000
-3.0%
1,481
-3.3%
0.05%
+16.3%
Q4 2017$99,000
+3.1%
1,5320.0%0.04%
-6.5%
Q3 2017$96,000
-18.6%
1,532
-21.2%
0.05%
-17.9%
Q2 2017$118,000
+35.6%
1,944
+15.4%
0.06%
+33.3%
Q1 2017$87,000
+97.7%
1,685
+69.3%
0.04%
+90.9%
Q4 2016$44,0009950.02%
Other shareholders
BAXTER INTL INC shareholders Q1 2022
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders